TBT Pharma
Baltimore, US · Founded 2019 · Delaware corporation · 1 known investors
Find your way into TBT Pharma
TBT Pharma is a biotech company developing repurposed generic drugs to replace topical steroids as the standard of care for skin conditions such as psoriasis, chronic wounds, and orphan skin diseases. Its approach relies on clinically validated data and exclusive patent licenses from NYU and Northwestern.
Founders & leadership
SG
Steve GirgentiNamed on SEC filing
Board
NC
IT
Investors · 1
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2020
▶$700KraisedJan 2021 · 4 investors · BiotechnologyRule 506(b)
▶$700KraisedJan 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Neil CohenDirector
- Ian TolfreeExecutive Officer, Director, Promoter
- Steve GirgentiDirector
- Offering amount
- $2M
- Amount sold
- $700K
- Minimum investment
- $25K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does TBT Pharma do?
- TBT Pharma is a biotech company developing repurposed generic drugs to replace topical steroids as the standard of care for skin conditions such as psoriasis, chronic wounds, and orphan skin diseases. Its approach relies on clinically validated data and exclusive patent licenses from NYU and Northwestern.
- Who are TBT Pharma's investors?
- TBT Pharma's investors include Emerald Development Managers.
- How much funding has TBT Pharma raised?
- TBT Pharma has disclosed $700K raised across 1 round.
- Where is TBT Pharma headquartered?
- TBT Pharma is headquartered in Baltimore, US.